{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T03:04:47Z","timestamp":1763348687395},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-024-06942-1","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T22:01:51Z","timestamp":1727820111000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of Epstein-Barr virus copy number in white blood cells of chronic lymphocytic leukemia patients with laboratory prognostic biomarker"],"prefix":"10.1186","volume":"17","author":[{"given":"Farkhondeh","family":"Azhdari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Faghih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirin","family":"Haghighat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzieh","family":"Jamalidoust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Younes","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohammad Ali","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamal","family":"Sarvari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"unstructured":"Saffar A, Rahgozar M, Shahi F, Biglarian A. Survival analysis of acute myeloid leukemia. Razi J Med Sci. 2015;22(134):41\u20138.","key":"6942_CR1"},{"issue":"6","key":"6942_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"Cancer J Clin"},{"issue":"12","key":"6942_CR3","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"Collaboration GBoDC","year":"2019","unstructured":"Collaboration GBoDC. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749\u201368.","journal-title":"JAMA Oncol"},{"issue":"11","key":"6942_CR4","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1002\/ajh.25595","volume":"94","author":"M Hallek","year":"2019","unstructured":"Hallek M. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment. Am J Hematol. 2019;94(11):1266\u201387.","journal-title":"Am J Hematol"},{"key":"6942_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11912-020-0893-0","volume":"22","author":"K Milne","year":"2020","unstructured":"Milne K, Sturrock B, Chevassut T. Chronic lymphocytic leukaemia in 2020: the future has arrived. Curr Oncol Rep. 2020;22:1\u20139.","journal-title":"Curr Oncol Rep"},{"issue":"10","key":"6942_CR6","first-page":"1621","volume":"63","author":"M Falay","year":"2017","unstructured":"Falay M, \u00d6zet G. Immunophenotyping of chronic lymphocytic leukemia. Clin Lab. 2017;63(10):1621\u20136.","journal-title":"Clin Lab"},{"issue":"1","key":"6942_CR7","first-page":"1","volume":"3","author":"TJ Kipps","year":"2017","unstructured":"Kipps TJ, Stevenson FK, Wu CJ, Croce CM, Packham G, Wierda WG, et al. Chronic lymphocytic leukaemia. Nat Reviews Disease Primers. 2017;3(1):1\u201322.","journal-title":"Nat Reviews Disease Primers"},{"issue":"1","key":"6942_CR8","doi-asserted-by":"publisher","first-page":"12070","DOI":"10.1038\/s41598-019-48445-1","volume":"9","author":"T Hao","year":"2019","unstructured":"Hao T, Li-Talley M, Buck A, Chen W. An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States. Sci Rep. 2019;9(1):12070.","journal-title":"Sci Rep"},{"issue":"2","key":"6942_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1200\/JCO.2016.68.2856","volume":"35","author":"Q Chen","year":"2017","unstructured":"Chen Q, Jain N, Ayer T, Wierda WG, Flowers CR, O\u2019Brien SM, et al. Economic burden of chronic lymphocytic leukemia in the era of oral targeted therapies in the United States. J Clin Oncol. 2017;35(2):166.","journal-title":"J Clin Oncol"},{"issue":"10","key":"6942_CR10","first-page":"606","volume":"20","author":"JN Allan","year":"2022","unstructured":"Allan JN. The clinical importance of prognostic markers in CLL. Clin Adv Hematol Oncology: H&O. 2022;20(10):606\u20138.","journal-title":"Clin Adv Hematol Oncology: H&O"},{"issue":"Spec Issue","key":"6942_CR11","first-page":"48","volume":"5","author":"A Ivanescu","year":"2012","unstructured":"Ivanescu A, Oprea M, Momanu R, Coles E, Colita A, Lupu A. Prognosis factors in chronic lymphocytic leukemia. J Med Life. 2012;5(Spec Issue):48.","journal-title":"J Med Life"},{"issue":"1","key":"6942_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1182\/asheducation-2010.1.77","volume":"2010","author":"RR Furman","year":"2010","unstructured":"Furman RR. Prognostic markers and stratification of chronic lymphocytic leukemia. Hematology 2010. Am Soc Hematol Educ Program Book. 2010;2010(1):77\u201381.","journal-title":"Am Soc Hematol Educ Program Book"},{"issue":"1","key":"6942_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11899-015-0294-x","volume":"11","author":"C Chen","year":"2016","unstructured":"Chen C, Puvvada S. Prognostic factors for chronic lymphocytic leukemia. Curr Hematol Malig Rep. 2016;11(1):37\u201342.","journal-title":"Curr Hematol Malig Rep"},{"issue":"4","key":"6942_CR14","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/annonc\/mdj120","volume":"17","author":"I Hus","year":"2006","unstructured":"Hus I, Podhorecka M, Bojarska-Junak A, Roli\u0144ski J, Schmitt M, Sieklucka M, et al. The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia. Ann Oncol. 2006;17(4):683\u201390.","journal-title":"Ann Oncol"},{"issue":"3","key":"6942_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.beha.2007.02.006","volume":"20","author":"T Zenz","year":"2007","unstructured":"Zenz T, D\u00f6hner H, Stilgenbauer S. Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia. Best Pract Res Clin Haematol. 2007;20(3):439\u201353.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"12","key":"6942_CR16","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1038\/sj.leu.2403147","volume":"17","author":"J D\u00fcrig","year":"2003","unstructured":"D\u00fcrig J, N\u00fcckel H, Cremer M, F\u00fchrer A, Halfmeyer K, Fandrey J, et al. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia. Leukemia. 2003;17(12):2426\u201334.","journal-title":"Leukemia"},{"issue":"5","key":"6942_CR17","first-page":"1923","volume":"112","author":"LZ Rassenti","year":"2008","unstructured":"Rassenti LZ, Jain S, Keating MJ, Wierda WG, Grever MR, Byrd JC, et al. Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. Blood J Am Soc Hematol. 2008;112(5):1923\u201330.","journal-title":"Blood J Am Soc Hematol"},{"issue":"21","key":"6942_CR18","doi-asserted-by":"publisher","first-page":"18653","DOI":"10.18632\/oncotarget.4418","volume":"6","author":"C Visco","year":"2015","unstructured":"Visco C, Falisi E, Young KH, Pascarella M, Perbellini O, Carli G, et al. Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival. Oncotarget. 2015;6(21):18653.","journal-title":"Oncotarget"},{"doi-asserted-by":"publisher","unstructured":"Rolinski J, Grywalska E, Bojarska-Junak A, Grabarczyk P. EBV infection leads to activation of chronic lymphocytic leukemia (CLL) cells and worsen clinical prognosis in CLL patients. Front Immunol. 2013. Conference Abstract: 15th International Congress of Immunology (ICI). https:\/\/doi.org\/10.3389\/conf.fimmu.2013.02.01073.","key":"6942_CR19","DOI":"10.3389\/conf.fimmu.2013.02.01073"},{"issue":"5","key":"6942_CR20","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/10428190500398856","volume":"47","author":"A-M Tsimberidou","year":"2006","unstructured":"Tsimberidou A-M, Keating MJ, Bueso-Ramos CE, Kurzrock R. Epstein-Barr virus in patients with chronic lymphocytic leukemia: a pilot study. Leuk Lymphoma. 2006;47(5):827\u201336.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"6942_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-9378-5-22","volume":"5","author":"R Dolcetti","year":"2010","unstructured":"Dolcetti R, Carbone A. Epstein-Barr virus infection and chronic lymphocytic leukemia: a possible progression factor? Infect Agents cancer. 2010;5(1):1\u20135.","journal-title":"Infect Agents cancer"},{"issue":"4","key":"6942_CR22","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/cncr.24839","volume":"116","author":"JJ Tarrand","year":"2010","unstructured":"Tarrand JJ, Keating MJ, Tsimberidou AM, O\u2019Brien S, LaSala RP, Han XY, Bueso-Ramos CE. Epstein\u2010Barr virus latent membrane protein 1 mRNA is expressed in a significant proportion of patients with chronic lymphocytic leukemia. Cancer: Interdisciplinary Int J Am Cancer Soc. 2010;116(4):880\u20137.","journal-title":"Cancer: Interdisciplinary Int J Am Cancer Soc"},{"issue":"10","key":"6942_CR23","doi-asserted-by":"publisher","first-page":"e0140178","DOI":"10.1371\/journal.pone.0140178","volume":"10","author":"E Grywalska","year":"2015","unstructured":"Grywalska E, Roli\u0144ski J, Pasiarski M, Korona-Glowniak I, Maj M, Surdacka A, et al. High viral loads of Epstein-Barr virus DNA in peripheral blood of patients with chronic lymphocytic leukemia associated with unfavorable prognosis. PLoS ONE. 2015;10(10):e0140178.","journal-title":"PLoS ONE"},{"issue":"7","key":"6942_CR24","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/NEJM200008173430707","volume":"343","author":"JI Cohen","year":"2000","unstructured":"Cohen JI. Epstein\u2013Barr virus infection. N Engl J Med. 2000;343(7):481\u201392.","journal-title":"N Engl J Med"},{"issue":"2","key":"6942_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.transci.2010.01.015","volume":"42","author":"DR Hardie","year":"2010","unstructured":"Hardie DR. Human \u03b3-herpesviruses: a review of 2 divergent paths to oncogenesis. Transfus Apheres Sci. 2010;42(2):177\u201383.","journal-title":"Transfus Apheres Sci"},{"issue":"13","key":"6942_CR26","doi-asserted-by":"publisher","first-page":"e00238","DOI":"10.1128\/JVI.00238-19","volume":"93","author":"A Saha","year":"2019","unstructured":"Saha A, Robertson ES. Mechanisms of B-cell oncogenesis induced by Epstein-Barr virus. J Virol. 2019;93(13):e00238\u201319.","journal-title":"J Virol"},{"issue":"10","key":"6942_CR27","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrc1452","volume":"4","author":"LS Young","year":"2004","unstructured":"Young LS, Rickinson AB. Epstein\u2013Barr virus: 40 years on. Nat Rev Cancer. 2004;4(10):757\u201368.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"6942_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-9378-10-5","volume":"10","author":"D Casabonne","year":"2015","unstructured":"Casabonne D, Benavente Y, Robles C, Costas L, Alonso E, Gonzalez-Barca E, et al. Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study. Infect Agents Cancer. 2015;10(1):1\u20137.","journal-title":"Infect Agents Cancer"},{"issue":"12","key":"6942_CR29","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrc.2016.92","volume":"16","author":"LS Young","year":"2016","unstructured":"Young LS, Yap LF, Murray PG. Epstein\u2013Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer. 2016;16(12):789\u2013802.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"6942_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/mp.52.6.307","volume":"52","author":"K Baumforth","year":"1999","unstructured":"Baumforth K, Young L, Flavell K, Constandinou C, Murray P. The Epstein-Barr virus and its association with human cancers. Mol Pathol. 1999;52(6):307.","journal-title":"Mol Pathol"},{"issue":"9","key":"6942_CR31","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1158\/1078-0432.CCR-10-3327","volume":"17","author":"S Hohaus","year":"2011","unstructured":"Hohaus S, Santangelo R, Giachelia M, Vannata B, Massini G, Cuccaro A, et al. The viral load of Epstein\u2013Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma. Clin Cancer Res. 2011;17(9):2885\u201392.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"6942_CR32","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/cam4.3669","volume":"10","author":"W Li","year":"2021","unstructured":"Li W, Chen J, Liang B, Li Z, Li J, Yuan X, et al. Long-term monitoring of dynamic changes in plasma EBV DNA for improved prognosis prediction of nasopharyngeal carcinoma. Cancer Med. 2021;10(3):883\u201394.","journal-title":"Cancer Med"},{"key":"6942_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40880-017-0256-x","volume":"36","author":"W-F Li","year":"2017","unstructured":"Li W-F, Zhang Y, Huang X-B, Du X-J, Tang L-L, Chen L, et al. Prognostic value of plasma Epstein\u2013Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy. Chin J cancer. 2017;36:1\u20139.","journal-title":"Chin J cancer"},{"issue":"2","key":"6942_CR34","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.18632\/oncotarget.6281","volume":"7","author":"J-H Liang","year":"2016","unstructured":"Liang J-H, Gao R, Xia Y, Gale RP, Chen R-Z, Yang Y-Q, et al. Prognostic impact of Epstein-Barr virus (EBV)-DNA copy number at diagnosis in chronic lymphocytic leukemia. Oncotarget. 2016;7(2):2135.","journal-title":"Oncotarget"},{"issue":"1","key":"6942_CR35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1182\/asheducation-2010.1.82","volume":"2010","author":"A Ferrajoli","year":"2010","unstructured":"Ferrajoli A. Treatment of younger patients with chronic lymphocytic leukemia. Hematology 2010. Am Soc Hematol Educ Program Book. 2010;2010(1):82\u20139.","journal-title":"Am Soc Hematol Educ Program Book"},{"issue":"10","key":"6942_CR36","first-page":"2044","volume":"114","author":"P Abrisqueta","year":"2009","unstructured":"Abrisqueta P, Pereira A, Rozman C, Aymerich M, Gin\u00e9 E, Moreno C, et al. Improving survival in patients with chronic lymphocytic leukemia (1980\u20132008): the Hospital Clinic of Barcelona experience. Blood. J Am Soc Hematol. 2009;114(10):2044\u201350.","journal-title":"J Am Soc Hematol"},{"issue":"1","key":"6942_CR37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3324\/haematol.2013.086066","volume":"99","author":"SA Parikh","year":"2014","unstructured":"Parikh SA, Rabe KG, Kay NE, Call TG, Ding W, Schwager SM, et al. Chronic lymphocytic leukemia in young (\u2264\u200955 years) patients: a comprehensive analysis of prognostic factors and outcomes. Haematologica. 2014;99(1):140.","journal-title":"Haematologica"},{"issue":"3","key":"6942_CR38","doi-asserted-by":"publisher","first-page":"693","DOI":"10.31557\/APJCP.2020.21.3.693","volume":"21","author":"A Tabibzadeh","year":"2020","unstructured":"Tabibzadeh A, Niya MHK, Esghaei M, Bokharaei-Salim F, Ataei-Pirkooh A, Kiani SJ, Monavari SHR. Molecular epidemiology of epstein-barr virus (ebv) in patients with hematologic malignancies. Asian Pac J Cancer Prevention: APJCP. 2020;21(3):693.","journal-title":"Asian Pac J Cancer Prevention: APJCP"},{"key":"6942_CR39","doi-asserted-by":"publisher","first-page":"200218","DOI":"10.1016\/j.tvr.2021.200218","volume":"12","author":"L Frappier","year":"2021","unstructured":"Frappier L. Epstein-Barr virus: current questions and challenges. Tumour Virus Res. 2021;12:200218.","journal-title":"Tumour Virus Res"},{"issue":"5673","key":"6942_CR40","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/274756a0","volume":"274","author":"G De-Th\u00e9","year":"1978","unstructured":"De-Th\u00e9 G, Geser A, Day N, Tukei P, Williams E, Beri D, et al. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt\u2019s lymphoma from Ugandan prospective study. Nature. 1978;274(5673):756\u201361.","journal-title":"Nature"},{"issue":"4","key":"6942_CR41","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ijc.2910290406","volume":"29","author":"A Geser","year":"1982","unstructured":"Geser A, De Th\u00e9 G, Lenoir G, Day N, Williams E. Final case reporting from the Ugandan prospective study of the relationship between Ebv and Burktit\u2019s lymphoma. Int J Cancer. 1982;29(4):397\u2013400.","journal-title":"Int J Cancer"},{"doi-asserted-by":"crossref","unstructured":"Tsimberidou A-M, Keating MJ, Bueso-Ramos C, Kurzrock R. Epstein-Barr Virus in patients with chronic lymphocytic leukemia. American Society of Hematology; 2005.","key":"6942_CR42","DOI":"10.1182\/blood.V106.11.2113.2113"},{"unstructured":"Alayvaz Aslan N, B\u00dcY\u00dcKA\u015eIK Y, SAYINALP N. The effect of prognostic features of patients with chronic lymphocytic leukemia on overall survival and treatment-free survival: a single-center experience. J Experimental Clin Med (Turkey). 2024;41(1).","key":"6942_CR43"},{"issue":"1","key":"6942_CR44","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1128\/JCM.37.1.132-136.1999","volume":"37","author":"H Kimura","year":"1999","unstructured":"Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol. 1999;37(1):132\u20136.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"6942_CR45","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1128\/JCM.40.11.3986-3992.2002","volume":"40","author":"SJ Stevens","year":"2002","unstructured":"Stevens SJ, Verkuijlen SA, Brule AJvd, Middeldorp JM. Comparison of quantitative competitive PCR with LightCycler-based PCR for measuring Epstein-Barr virus DNA load in clinical specimens. J Clin Microbiol. 2002;40(11):3986\u201392.","journal-title":"J Clin Microbiol"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-024-06942-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-024-06942-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-024-06942-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T23:04:51Z","timestamp":1727823891000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-024-06942-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6942"],"URL":"https:\/\/doi.org\/10.1186\/s13104-024-06942-1","relation":{},"ISSN":["1756-0500"],"issn-type":[{"type":"electronic","value":"1756-0500"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"assertion":[{"value":"14 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local Ethics Committee of Shiraz University of Medical Sciences (IR.SUMS.REC.1398.405). Written informed consent was obtained from participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"281"}}